Connection

HUSSEIN TAWBI to Mitogen-Activated Protein Kinase 3

This is a "connection" page, showing publications HUSSEIN TAWBI has written about Mitogen-Activated Protein Kinase 3.
  1. Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors. JCI Insight. 2018 02 22; 3(4).
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.